Atea Pharmaceuticals, Inc. - AVIR
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 13
Latest filed: Mar 26, 2026
| Form | Count |
|---|---|
| 4 | 7 |
| 8-K | 3 |
| SCHEDULE 13G/A | 2 |
| SCHEDULE 13G | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| Mar 26, 2026 | SCHEDULE 13G/A | — | 0000102909-26-000786 | View |
| Mar 13, 2026 | 4 | Mar 11, 2026 | 0001193125-26-106547 | View |
| Mar 05, 2026 | 8-K | Mar 05, 2026 | 0001193125-26-093961 | View |
| Feb 09, 2026 | SCHEDULE 13G | — | 0001373604-26-000010 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036261 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036268 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036269 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036270 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036272 | View |
| Feb 03, 2026 | 4 | Jan 31, 2026 | 0001193125-26-036281 | View |
| Jan 08, 2026 | 8-K | Jan 08, 2026 | 0001193125-26-007081 | View |
| Dec 05, 2025 | SCHEDULE 13G/A | — | 0000315066-25-002957 | View |
| Nov 12, 2025 | 8-K | Nov 12, 2025 | 0001193125-25-277627 | View |